Lupin has received certification for International Sustainability Rating Standard, 8th edition (ISRS) from Det Norske Veritas (DNV), a global provider of services for managing risk, helping customers to safely and responsibly improve their business performance. The certification was received after audits were conducted at three of the company's manufacturing facilities in India located at Ankleshwar, Mandideep and Tarapur. Lupin is the first pharmaceutical company globally to have received this ISRS 8th edition certification
ISRS is a world leading system to assess, improve and demonstrate the health of an organization's business processes. Using ISRS ensures operations are safe and sustainable and helps improve and demonstrate safety, environmental, and sustained business operations / performance.
Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1883.75 |
| Dr. Reddys Lab | 1290.80 |
| Cipla | 1340.10 |
| Zydus Lifesciences | 943.70 |
| Lupin | 2250.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: